CAPS Rating: 2 out of 5


Player Avatar fox2man2 (< 20) Submitted: 10/6/2012 12:38:50 AM : Outperform Start Price: $10.29 OMER Score: +82.94

I believe OMER will outperform the S&P 500 by a considerable amount. I encourage Fools to go to its website and read about recent developments in its propieteray medical programs. That is a 15 minute task and well worth one's time. OMER has no income at this time, but expects approval of two drugs in 2013, one for arthroscopic knee surgery and a second for eye surgery. Daily trading volume has been small, however, and this should be considered by prospective investors.

Featured Broker Partners